SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VISX -- Ignore unavailable to you. Want to Upgrade?


To: MGV who wrote (1632)2/22/2000 6:31:00 PM
From: MGV  Read Replies (1) | Respond to of 1754
 
Bottomline: 1 year from today, VISX is up at least 50% from today's close. If volume increases by only 33%, and market share is flat, they make north of $1.00 in 2001 and north of 1.50 in 2002. With a 30 multiple they would be reasonably priced north of $40. I would buy at $18 and at $20.



To: MGV who wrote (1632)2/22/2000 6:33:00 PM
From: mts362  Read Replies (2) | Respond to of 1754
 
forecast for procedure volume in 2000 was about 1.5 Million.

1.5mil in '00 is higher than anything I've seen recently. Goldman, SG Cowen, and ING Barings estimate 1.2mm, 1.375mm, and 1.35mm, respectively.

If procedure volume accelerates by 50%...

Also very aggressive

Add incremental service and laser sale revenue and the shortfall is less.

Service should be flat this year, and laser sales should decline each of the next 3 years.

I agree that VISX, now @ $17-18, is very cheap. I just think your #s are aggressive